共 29 条
Reliability, Validity, and Responsiveness of the Patient-Specific Functional Scale for Measuring Mobility-Related Goals in People With Multiple Sclerosis
被引:4
|作者:
Manago, Mark M.
[1
,2
,3
,7
]
Cohen, Evan T.
[4
]
Cameron, Michelle H.
[5
,6
]
Christiansen, Cory L.
[1
,3
]
Bade, Michael
[1
,3
]
机构:
[1] Univ Colorado, Dept Phys Med & Rehabil, Phys Therapy Program, Aurora, CO USA
[2] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA
[3] VA Eastern Colorado Healthcare Syst, Geriatr Res Educ & Clin Ctr, Denver, CO USA
[4] Arcadia Univ, Dept Phys Therapy, Glenside, PA USA
[5] Oregon Hlth & Sci Univ, Sch Med, Dept Neurol, Portland, OR USA
[6] VA Portland Hlth Care Syst, Portland, OR USA
[7] CU Phys Therapy Program, Mail Stop C244, 13121 E 17th Ave, Room 3108, Aurora, CO 80045 USA
来源:
JOURNAL OF NEUROLOGIC PHYSICAL THERAPY
|
2023年
/
47卷
/
03期
基金:
美国国家卫生研究院;
关键词:
multiple sclerosis;
outcome measures;
psychometrics;
reliability;
validity;
TIMED 25-FOOT WALK;
INTERNATIONAL CLASSIFICATION;
CLINIMETRICS CORNER;
OUTCOME MEASURES;
DISABILITY;
MS;
D O I:
10.1097/NPT.0000000000000439
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
Background and Purpose: This study's purpose was to investigate the reliability, validity, and responsiveness of the Patient-Specific Functional Scale (PSFS) for measuring mobility-related goals in people with multiple sclerosis (MS).Methods: Data from 32 participants with MS who underwent 8 to 10 weeks of rehabilitation were analyzed (Expanded Disability Status Scale scores 1.0-7.0). For the PSFS, participants identified 3 mobility-related areas where they had difficulty and rated them at baseline, 10 to 14 days later (before starting intervention), and immediately after intervention. Test-retest reliability and response stability of the PSFS were calculated using the intraclass correlation coefficient (ICC2,1) and minimal detectable change (MDC95), respectively. Concurrent validity of the PSFS was determined with the 12-item Multiple Sclerosis Walking Scale (MSWS-12) and the Timed 25-Foot Walk Test (T25FW). PSFS responsiveness was determined using Cohen's d, and minimal clinically important difference (MCID) was calculated based on patient-reported improvements on a Global Rating of Change (GRoC) scale.Results: The PSFS total score demonstrated moderate reliability (ICC2,1 = 0.70, 95% CI: 0.46 to 0.84) and the MDC was 2.1 points. At baseline, the PSFS was fairly and significantly correlated with the MSWS-12 (r = -0.46, P = 0.008) but not with the T25FW. Changes in the PSFS were moderately and significantly correlated with the GRoC scale (? = 0.63, P < 0.001), but not with MSWS-12 or T25FW changes. The PSFS was responsive (d = 1.7), and the MCID was 2.5 points or more to identify patient-perceived improvements based on the GRoC scale (sensitivity = 0.85, specificity = 0.76).Discussion and Conclusions: This study supports the use of the PSFS as an outcome measure in people with MS to assess mobility-related goals.Video Abstract available for more insights from the authors.
引用
收藏
页码:139 / 145
页数:7
相关论文